Cell Therapy News Volume 22.02 | Jan 18 2021

    0
    60






    CTN 22.02 | Jan 18 2021


    Cell Therapy News by STEMCELL Technologies
    Vol. 22.02 – 18 January, 2021
    TOP STORY

    Chaperone-Mediated Autophagy Sustains Hematopoietic Stem-Cell Function

    Scientists showed that chaperone-mediated autophagy 5, a selective form of lysosomal protein degradation, was involved in sustaining hematopoietic stem cell function in adult mice.
    [Nature]

    Abstract


    Request your free copy of the 'Production of Chimeric Antigen Receptor T Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    Low-Dose
    Decitabine Priming Endows CAR T Cells with Enhanced and Persistent Antitumor Potential via Epigenetic Reprogramming

    Antitumor activities, cytokine production, and proliferation were enhanced in decitabine-treated chimeric antigen receptor T cells both in vitro and in vivo.
    [Nature Communications]

    Full Article

    Adoptive
    Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy

    Researchers analyzed the safety and evaluate preliminary efficacy of polyomavirus JC-specific T cell therapy in a cohort of hematological patients with Progressive Multifocal Leukoencephalopathy.
    [Annals of Neurology]

    Abstract

    Aging
    of Human Hematopoietic Stem Cells Is Linked to Changes in Cdc42 Activity

    Investigators report increased frequencies of hematopoietic stem cell (HSC), HPC and lineage negative cells in the elderly but a decreased frequency of multi-lymphoid progenitors. Aged human HSCs further exhibited a delay in initiating division ex vivo though without changes in their division kinetics.
    [Haematologica]

    Abstract

    Successful
    Gene Therapy of Diamond-Blackfan Anemia in a Mouse Model and Human CD34+ Cord Blood Hematopoietic Stem Cells Using a Clinically Applicable Lentiviral Vector

    The authors observed that transduced ribosomal protein S19 (Rps19)-deficient bone marrow cells could reconstitute mice long term and rescue the bone marrow failure and severe anemia observed in Rps19-deficient mice, with a low risk of mutagenesis and a highly polyclonal insertion site pattern.
    [Haematologica]

    Abstract

    Surgical
    Transplantation of Human RPE Stem Cell-Derived RPE Monolayers into Non-Human Primates with Immunosuppression

    Scientists placed human retinal pigment epithelium (RPE) stem cell-derived RPE monolayers under the macula of a non-human primate model for three months.
    [Stem Cell Reports]

    Full Article

    Development
    of a Dual Hybrid AAV Vector for Endothelial-Targeted Expression of Von Willebrand Factor

    Researchers aimed at developing a gene therapy strategy for gene delivery into endothelial cells, the natural site of biosynthesis of Von Willebrand disease.
    [Gene Therapy]

    Full Article

    The
    Adverse Events of Hematopoietic Stem Cell Transplantation Are Associated with Gene Polymorphism within Human Leukocyte Antigen Region

    The authors investigated the correlation between the gene polymorphisms within the HLA region and the adverse reactions of post-hematopoietic stem cell transplantation in patients with acute leukemia, where 72 patients were diagnosed with acute lymphocytic leukemia and 104 were acute myeloid leukemia.
    [Scientific Reports]

    Full Article


    Explore the Science Events Calendar to discover conferences, podcasts, webinars, and more!
    REVIEWS

    Nanomaterials for T-Cell Cancer Immunotherapy

    Scientists present an overview of nanomaterials that have been used to overcome clinical barriers to T-cell-based immunotherapies and provide their outlook of this emerging field at the interface of cancer immunotherapy and nanomaterial design.
    [Nature Nanotechnology]

    Full Article

    Consensus
    Opinion on Immune-Mediated Cytopenias after Hematopoietic Cell Transplant for Inherited Metabolic Disorders

    The authors summarize the literature, provide an approach to better understanding of the possible etiology of immune mediated cytopenias, and propose a diagnostic and management plan for patients with inherited metabolic disorders who develop single or multi-lineage cytopenias after hematopoietic stem cell transplantation.
    [Bone Marrow Transplantation]

    Full Article

    INDUSTRY AND POLICY NEWS

    Adocia
    Files Patent on a Hydrogel Scaffold for Cell Therapy in the Treatment of Type 1 Diabetes

    Adocia announced it has developed a hydrogel scaffold that hosts and protects pancreatic β cells for replacement of the missing cells of people with type 1 diabetes.
    [Adocia]

    Press Release

    FEATURED EVENT

    Stanford Diabetes Research Center: Insulin 100th Birthday Celebration

    February 18, 2021
    Virtual


    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Tumor Biology and Therapeutic Applications

    Harvard Medical School – Boston, Massachusetts, United States

    Experimental Genetics Researcher – IBS, and the Immune/Microbiome/Endothelial Axis

    University of California San Francisco – San Francisco, California, United States

    Postdoctoral Fellowship – Stem Cell Biology/Lung Biology

    University of California, San Francisco – San Francisco, California, United States


    Research Lab Specialist – Genome Editing and Sickle Cell Disease

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral
    Positions – Gene Regulation in Skeletal Muscle Stem Cells and Embryonic Stem Cells

    National Institute of Arthritis and Musculoskeletal and Skin Diseases – Washington, DC, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Cell Therapy News
    Archives Contact Us
    Cell Therapy News Twitter